Immunotherapy (IT) has become an accepted therapeutic modality for a limited number of tumor types. One of the limiting factors in the use of interleukin-2 (IL-2) has been dose-related toxicity. We undertook these studies to study the effects of combined therapy on a murine melanoma. The B 16 melano
Local hyperthermia and systemic chemotherapy for treatment of recurrent melanoma
✍ Scribed by Franco Filippo; Sandro Carlini; Rosa Garinei; Pasquale Perri; Michele Anzà; Francesca Ferranti; Elena Saracca; Monica Schiratti; Francesco Cavaliere; Renato Cavaliere
- Publisher
- Springer
- Year
- 1995
- Tongue
- English
- Weight
- 415 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0364-2313
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We examined retrospectively the results of hyperthermia combined with irradiation and chemotherapy (HCR) prescribed preoperatively for patients with adenocarcinoma of the rectum. We compared two groups of patients: Group A: 23 were treated surgically between 1986-1988 and received HCR therapy; group
Recently, Langer et al. reported "the first instance of an adult with nodular sclerosing Hodgkin (sic) disease who had thymic hyperplasia develop after clinical and radiographic com- plete remission (CR) with chemotherapy alone."' Actually, Shin and Ho2 reported a case of diffuse thymic hyperplasia